Knowledge Centre

Healthy Ageing 2023 was the annual conference led by UKRI’s Healthy Ageing Challenge, led by Innovate UK and the Economic and Social Research Council (ESRC), which over the past 5 years invested £98 million in research and innovation across the UK to ensure that people, as they age, can remain active, productive, independent, and socially connected across generations for as long as possible.

Dr Marcus Ong’s business mantra is the same approach he learnt as a science student at university: “always question everything.” It was that instinct that drove him to transform a consultancy firm into an innovative software company Patchs Health, which is focused on solving the problems facing Britain’s health service through the application of AI.

Watch the recording of our 22 Janaury London leg of the Innovate UK Immersive Technology Network University Tour, in collaboration with and hosted at King’s College London.

Don’t miss out on the incredible opportunity to be part of Materials Research Exchange (MRE2024).

Join us in Cardiff on 12 December for the Immerse UK Tour, in collaboration with Wales Millennium Centre, Cardiff University, Media Cymru and University of South Wales.

Global Alliance Africa, a project of Innovate UK, organised a trip to in Lagos, Nigeria, with a primary emphasis on fostering innovative solutions within the nation’s burgeoning circular fashion industry. The trip aimed to unlock the potential of Nigeria’s Circular Fashion sector for substantial contributions to both the economy and global recognition.

Please join us for an update from Innovate UK on place-based transport decarbonisation and opportunities.

We invite the broader UK transport R&D community to join this webinar for information on the Horizon Europe Cluster 5 Calls.

Cumulus Neuroscience is reshaping the landscape of clinical trials. This Belfast-based health tech company is making it possible to capture valuable cognitive and behavioural data from patients taking part in clinical studies, all from the comfort of their home. The digital biomarkers emerging from these studies have the potential to transform the pace at which new treatments for neurodegenerative and neuropsychiatric conditions are discovered.